Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence?

Sun, L; Duarte, S; Soares-de-Almeida, L

Sun, L; Duarte, S; Soares-de-Almeida, L.

Sun L; Dermatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Duarte S; Dermatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Soares-de-Almeida L; Dermatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.

J Eur Acad Dermatol Venereol ; 36(7): e514-e516, 2022 07.

Article in English | MEDLINE | ID: covidwho-1741441

Subject(s)

COVID-19; ChAdOx1 nCoV-19; Hyperpigmentation; Lichen Planus; COVID-19/prevention & control; ChAdOx1 nCoV-19/adverse effects; Humans; Hyperpigmentation/chemically induced; Lichen Planus/chemically induced

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hyperpigmentation / COVID-19 / ChAdOx1 nCoV-19 / Lichen Planus Type of study: Case report / Observational study Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18058

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google